BTTC08-01: A phase II study of bevacizumab and erlotinib after radiation therapy and temozolomide in patients with newly diagnosed glioblastoma (GBM) without MGMT promoter methylation.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jeffrey J. Raizer, Pierre Giglio, Jethro Lisien Hu, Morris D. Groves, Ryan Merrell, Charles A. Conrad, Surasak Phuphanich, Vinay K. Puduvalli, Monica Elena Loghin, Nina Paleologos, W. K. Alfred Yung, Brian D. Vaillant, Jeremy David Rudnick, Marc C. Chamberlain, Nicholas Vick, Sean Aaron Grimm, Ivo Tremont-Lukats, John Frederick De Groot, Kenneth D. Aldape, Mark R. Gilbert
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2586591937